检索

标题
作者
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V., Shamkhalova M., Duganova A.
Features of the course of COVID-19 in patients with type 2 diabetes mellitus
Karaseva E., Martynov V., Filatova T., Maleev V., Grishin V., Pronin N., Verbitskaya E., Popova V.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
Petunina N., Telnova M., Goncharova E., Martirosian N., Kuzina I.
Neural networks in the predictive diagnosis of cognitive impairment in type 1 and type 2 diabetes mellitus
Samoilova I., Matveeva M., Kudlay D., Tonkikh O., Tolmachev I.
Long-term uroseptic and metabolic effects of a herbal medicinal preparation in women with type 2 diabetes taken gliflosins
Tsygankova O., Timoshchenko O., Apartseva N., Latyntseva L.
The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins
Tsygankova O., Evdokimova N., Timoshchenko O., Latyntseva L.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Adipokines and the cardiorespiratory system in young patients with type 1 diabetes mellitus
Vengrzhinovskaya O., Bondarenko I., Shatskaya O., Nikankina l., Kalashnikov V., Shestakova M., Mokrysheva N.
Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry)
Oschepkova E., Aksenova A., Orlovsky A., Chazova I.
SGLT2 inhibitors in acute decompensated heart failure, what do we know?
Lapteva A., Nasonova S., Zhirov I., Tereshchenko S.
Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review
Demidova T., Titova V., Izmaylova M.
Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
Rasskazova M., Vorobyev S., Butova H.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O., Martynov A., Arutyunov G., Bakulin I., Livzan M., Maev I., Egorov I.
Type 2 diabetes mellitus and coronary artery disease: features of perfusion volume computed tomography of the heart in a pharmacological test with adenosine triphosphate
Soboleva G., Minasyan A., Gaman S., Rogoza A., Molina L., Soboleva T., Shariya M., Ternovoy S., Karpov Y.
Ala54Thr polymorphism of the fatty acid transporter gene (FABP2) in patients with type 2 diabetes mellitus in Yakutia
Sydykova L., Pavlova N., Bochurov A., Alekseev V., Krylov A., Kurtanov K., Shestakova M.
Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review
Samoilova I., Vaizova O., Stankova A., Matveeva M., Podchinenova D., Kudlay D., Borozinets A., Filippova T., Grishkevich I., Partala A., Gerasimova D.
Clinical importance of evaluation of circulating miRNA expression and epicardial adipose tissue thickness as predictors of cardiovascular pathology in young patients with type 1 diabetes mellitus
Vengrzhinovskaya O., Bondarenko I., Shatskaya O., Tarbaeva N., Korneluk A., Kalashnikov V., Shestakova M., Mokrysheva N.
Diabetes mellitus type 2: National Russian guidelines vs real clinical practice
Shestakova M., Vikulova O., Zheleznyakova A., Dedov I., Mokrysheva N.
Comparative analysis of the drugs efficacy for carbohydrate metabolism early disorders (prediabetes) treatment: A review
Mkrtumyan A.
The attitude of patients with types 1 and 2 diabetes mellitus towards having the disease
Sapozhnikova I., Zotina E.
Polymorphic variants of glutathione reductase – new genetic markers of predisposition to type 2 diabetes mellitus
Azarova I., Klyosova E., Polonikov A.
Hypoglycemia in patients with type 2 diabetes mellitus: Safe solution of the dangerous problem
Shestakova M., Khalimov I.
The prevalence of components of metabolic syndrome in the patients with diabetes melitus type 2 and mody diabetes in young people of Novosibirsk
Mustafina S., Ovsyannikova A., Voevoda M., Denisova D., Sherbakova L., Rymar O.
Obesity without diabetes: the role of hormonal regulation
Shestakova E., Sklyanik I., Panevina A., Nikankina L., Shestakova M., Dedov I.
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria
Sturov N., Popov S., Mamporia N., Mager A.
Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion
Dedov I., Melnichenko G., Troshina E., Ershova E., Mazurina N., Ogneva N., Yashkov Y., Ilyin А.
Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
Larina I., Severina A., Shamkhalova M., Shestakova M.
Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus
Vikulova O., Zuraeva Z., Michaleva O., Nikankina L., Shamkhalova M., Shestakova M., Dedov I.
Experience with "AlfaVit Diabetes" used in the treatment of diabetic peripheral polyneuropathy in adolescents
Azova E., Vorob'eva V., Chekalova S., Okulova O., Azov N., Kolbasina E., Belotserkovskaia O., Severukhina T., Sladkova I.
Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
Arutyunova M., Glazunova A., Mikhaleva O., Zuraeva Z., Martynov S., Klefortova I., Manchenko O., Ulyanova I., Ilyin A., Shamkhalova M., Shestakova M.
Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
Efremova N., Bolotskaya L., Atarshchikov D., Bondarenko O., Ilyin A., Shestakova M.
Latent forms of adult-onset autoimmune polyglandular syndrome: Diagnosis and management of patients
Larina A., Troshina E.
The contribution of current investigations to understanding the nature of type 2 diabetes mellitus, and treatment perspectives
Ametov A.
Carbohydrate metabolic disturbances and obstructive sleep apnea syndrome
Oleĭnikov V., Sergatskaia N.
The incidence of postoperative myocardial infarction and the left ventricular function in patients with type 2 diabetes mellitus after recanalization of chronic coronary occlusions
Petrenko I., Petrenko O., Popova M., Mamedova S., Urvantseva I.
Innovations in the treatment of type 2 diabetes mellitus: use of incretins
Dedov I., Shestakova M., Sukhareva O., Dedov I., Shestakova M., Sukhareva O.
The role of hypersympathycotony in development of arterial hypertensionin patients with metabolic syndrome: potential of pathogenetically sound therapy
Ametov A., Demidova T., Smagina L.
A lipid profile of blood plasm inpatients with metabolic syndrome and manifest disorder ofcarbohydrate metabolism
Medvedeva I., Dorodneva E., Pugacheva T., Bekhikova L., Zhuravleva T.
Nephrolithiasis against type 2 diabetes mellitus: on the effect of hypoglycemic therapy on lithogenesis
Yarovoy S., Kareva E., Djalilov O.
Leptin, resistin, and hormonal and metabolic parameters in women with type 2 diabetes and in those with its concurrence with asthma
Verbovoy A., Kosareva O., Akhmerova R.
Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention
Shishkova V.
Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy
Statsenko M., Derevianchenko M.
The degree of alexithymia in type 2 diabetes mellitus patients and its association with medical and demographic parameters
Sapozhnikova I., Tarlovskaia E., Madianov I., Vedenskaia T.
Taurin in combined treatment of metabolic syndrome and diabetes mellitus
Ametov A., Kochergina I., Doskina E., Abaeva B., Elizarova E., Ametov A., Kochergina I., Doskina E., Abaeva B., Elizarova E.
Inflammation as a factor of the pathogenesis of insulin resistance and type 2 diabetes
Shvarts V., Schwarz V.
Angiogenesis system, as a part of endothelial dysfunction in patients with diabetes mellitus type 2: relationship with obesity
Severina A., Shestakova M.
Efficacy of ivabradine in combination therapy for complicated acute coronary syndrome in patients with type 2 diabetes mellitus
Kondrat'ev A., Dolgikh V., Stotskiy A., Kondratyev A., Dolgikh V., Stotsky A.
Risk of type 2 diabetes mellitus in the Kyrgyz population in the presence of ADIPOQ (G276T), KCNJ11 (Glu23Lys), TCF7L2 (IVS3C>T) gene polymorphisms
Isakova Z., Talaibekova E., Asambaeva D., Kerimkulova A., Lunegova O., Aldasheva N., Aldashev A.
Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency
Bakulin I., Sandler Y., Vinnitskayа E., Keiyan V., Rodionova S., Rotin D.
The state of the great arteries in type 2 diabetes mellitus patients with obstructive sleep apnea syndrome
Oleynikov V., Sergatskaya N., Gusakovskaya L., Khromova A.
1 - 50 的 115 信息 1 2 3 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##